Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow CLDN7 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • Clindamycin B 2-Phosphate antibiotic blog
 • ITM2C sirna blog
 • CSNK2A2 sirna blog
 • GABRA5 elisa kit blog
 • Rat Anti-Mouse IgE (epsilon chain specific) secondary antibody blog
 • mmu-miR-615-3p mirna blog
 • CFC1 shrna blog
 • ZNF18 sirna blog
 • SOX12 sirna blog
 • Tissue, Total Protein, Monkey lysate blog
 • anti-SYP antibody blog
 • NMB sirna blog
 • Ivermectin antibiotic blog
 • PAX5 peptide blog
 • NMDA inhibitor blog
 • anti-CD31 antibody blog
 • DEFB107A shrna blog
 • PLK3 blocking peptide blog
 • HSD11B1 sirna blog
 • DDX52 sirna blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • Ras protein-specific guanine nucleotide-releasing factor 2 (... ELISA Kit
 • ATG5 Antibody
 • TALIN1 Antibody
 • BRAP Antibody
 downarrow more ...

CLDN7 sirna product blog

Posted on 2017-05-07 08:31:35 by mybiosource_staff
Share it on ...     
Tags: CLDN7; siRNA; CLDN7 sirna;
The CLDN7 cldn7 (Catalog #MBS8205578) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The CLDN7 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CLDN7 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the CLDN7 cldn7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The CLDN7 cldn7 product has the following accession number(s) (GI #297206811) (NCBI Accession #NP_001171951.1) (Uniprot Accession #O95471). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit CLDN7 expression using RNA interference.

CLDN7 cldn7

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human CLDN7 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo. Blood, Embryonic Tissue, Intestine, Kidney, Liver, Lung, Lymph Node, Pancreas, Prostate, Stomach tissues are correlated with this protein. CLDN7 also interacts with the following gene(s): CD9, CDH1, ELF3, EPCAM, SMAD4, SNAI1, TJP1. Adenocarcinoma, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Inflammation, Kidney Diseases, Liver Diseases, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis are some of the diseases may be linked to CLDN7 siRNA (Human). The following patways have been known to be associated with this gene.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions